Skip to content
TriangleGet started
← Back to this collection

PUBLICATIONS · 23177514

Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet
Publication date
2013 Jan 26
First author
Grothey A

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet. 2013 Jan 26;381(9863):273-5. doi: 10.1016/S0140-6736(12)62006-6.
    note
    Source null
    related pmid
    23177516
    relationship
    Comment in
  2. citation
    Nat Rev Clin Oncol. 2013 Jan;10(1):1. doi: 10.1038/nrclinonc.2012.222.
    note
    Source null
    related pmid
    23229184
    relationship
    Comment in
  3. citation
    Nat Rev Gastroenterol Hepatol. 2013 Jan;10(1):1. doi: 10.1038/nrgastro.2012.242.
    note
    Source null
    related pmid
    23229325
    relationship
    Comment in
  4. citation
    Lancet. 2013 May 4;381(9877):1536-7. doi: 10.1016/S0140-6736(13)60975-7.
    note
    Source null
    related pmid
    23642693
    relationship
    Comment in
  5. citation
    Lancet. 2013 May 4;381(9877):1537-8. doi: 10.1016/S0140-6736(13)60977-0.
    note
    Source null
    related pmid
    23642695
    relationship
    Comment in
  6. citation
    Lancet. 2013 May 4;381(9877):1537. doi: 10.1016/S0140-6736(13)60976-9.
    note
    Source null
    related pmid
    23642696
    relationship
    Comment in
  7. citation
    Lancet. 2013 May 4;381(9877):1538-9. doi: 10.1016/S0140-6736(13)60978-2.
    note
    Source null
    related pmid
    23642697
    relationship
    Comment in

Authors and identifiers

  1. name
    Grothey A
    type
    Author
  2. name
    Van Cutsem E
    type
    Author
  3. name
    Sobrero A
    type
    Author
  4. name
    Siena S
    type
    Author
  5. name
    Falcone A
    type
    Author
  6. name
    Ychou M
    type
    Author
  7. name
    Humblet Y
    type
    Author
  8. name
    Bouché O
    type
    Author
  9. name
    Mineur L
    type
    Author
  10. name
    Barone C
    type
    Author
  11. name
    Adenis A
    type
    Author
  12. name
    Tabernero J
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Grothey A
    type
    Author
  2. name
    Van Cutsem E
    type
    Author
  3. name
    Sobrero A
    type
    Author
  4. name
    Siena S
    type
    Author
  5. name
    Falcone A
    type
    Author
  6. name
    Ychou M
    type
    Author
  7. name
    Humblet Y
    type
    Author
  8. name
    Bouché O
    type
    Author
  9. name
    Mineur L
    type
    Author
  10. name
    Barone C
    type
    Author
  11. name
    Adenis A
    type
    Author
  12. name
    Tabernero J
    type
    Author
bibliography ids
  1. nci-bib-ff9d2387e9c61f9130b0ccbb
book metadata
content sha256
a4fe762f365ba53d9ff02f6e6525ec0e5b7d18f805fbb017f174c30364202b83
document type
citation
dois
  1. 10.1016/S0140-6736(12)61900-X
electronic publication date
display
2012 Nov 22
precision
day
year
2012
evidence scope
bibliographic_metadata_only
id
pubmed:23177514
immutable id
pubmed:23177514@a4fe762f365ba53d9ff02f6e6525ec0e5b7d18f805fbb017f174c30364202b83
journal
abbreviation
Lancet
issn electronic
1474-547X
issn print
0140-6736
issue
9863
name
Lancet (London, England)
nlm unique id
2985213R
pages
303-12
volume
381
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet. 2013 Jan 26;381(9863):273-5. doi: 10.1016/S0140-6736(12)62006-6.
    note
    Source null
    related pmid
    23177516
    relationship
    Comment in
  2. citation
    Nat Rev Clin Oncol. 2013 Jan;10(1):1. doi: 10.1038/nrclinonc.2012.222.
    note
    Source null
    related pmid
    23229184
    relationship
    Comment in
  3. citation
    Nat Rev Gastroenterol Hepatol. 2013 Jan;10(1):1. doi: 10.1038/nrgastro.2012.242.
    note
    Source null
    related pmid
    23229325
    relationship
    Comment in
  4. citation
    Lancet. 2013 May 4;381(9877):1536-7. doi: 10.1016/S0140-6736(13)60975-7.
    note
    Source null
    related pmid
    23642693
    relationship
    Comment in
  5. citation
    Lancet. 2013 May 4;381(9877):1537-8. doi: 10.1016/S0140-6736(13)60977-0.
    note
    Source null
    related pmid
    23642695
    relationship
    Comment in
  6. citation
    Lancet. 2013 May 4;381(9877):1537. doi: 10.1016/S0140-6736(13)60976-9.
    note
    Source null
    related pmid
    23642696
    relationship
    Comment in
  7. citation
    Lancet. 2013 May 4;381(9877):1538-9. doi: 10.1016/S0140-6736(13)60978-2.
    note
    Source null
    related pmid
    23642697
    relationship
    Comment in
outcomes validated
false
pmid
23177514
provenance
batch id
99e85dbb34a1a3011c9a
provider
NCBI PubMed ESummary
record sha256
1bdc66b1fc2ec4bda9b70bb6e0c67d0d156d173ece9d998ba8b93f7a8e53f320
response sha256
1f4a46dcee9da36f8f58fe356dce3f44a1b3004f404e9fb0184f4e08aed4acf2
retrieved at
2026-09-09T23:46:52.860383+00:00
publication date
display
2013 Jan 26
precision
day
year
2013
publication types
  1. Clinical Trial, Phase III
  2. Journal Article
  3. Multicenter Study
  4. Randomized Controlled Trial
  5. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/23177514/
title
Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial.

Preserved source evidence · Independent clinical review pending · Not medical advice